Patient Care
- Find a Doctor
  Find a doctor by specialty or location.
- Care Locations
  Find primary and specialty care near you.
- Departments and Centers
  New knowledge driving discovery to advance the health of our communities.
- Research
  Every discovery advances academic medicine and improves the vitality of our communities.
- Pay a Bill
  Pay a a bill for services performed by MCW.
- Contact
  Let us help you find an answer to your question.
- MyChart Login
  MyChart user? Log in to make an appointment.
- Request an Appointment Online
  Or call Adult Specialties (800) 272-3666 or Pediatric Specialties (877) 607-5280.
Education
- Medical School
  Choose from a three or four-year MD program at various campus locations, our anesthesiologist assistant or a number of dual degree programs.
- Graduate School
  Designed to provide a unique, specialized learning experience.
- Pharmacy School
  An innovative three-year PharmD program designed for the expanding pharmacist role in patient care.
- Residency and Fellowship Programs
  Choose from more than 140 specialties and sub-specialties for advanced medical training at MCW.
- Commencement
  MCW Commencement Events – All Campuses
Research
- Basic Science Research
  Our scientists are discovery-drivers, working to develop cutting-edge treatments.
- Clinical Trials
  Clinical trials are invaluable in testing new treatments, drugs and technologies.
- Translational Research
  Translational scientists turn science and research into improved treatments.
- Centers
  Through collaboration with the brightest minds in science and medicine MCW’s Centers are at the forefront of discovery and innovation.
Community
- Advancing a Healthier Wisconsin Endowment
  Through research, health care education, workforce development, and community health initiatives, AHW drives change.
- Community Engagement
  Enhancing learning, research, patient care and the health of the community.
- Institute for Health & Equity
  A hub focused on population health, biostatistics, bioethics and epidemiology research.
Giving
- Accelerating and Advancing Patient Care
  We’re challenging existing models of care with new ideas across the spectrum of discovery—from basic science, to clinical trials, to public policy changes.
- Transforming Healthcare Education
  We are committed to transforming how we educate healthcare professionals and inspire the diverse, fully skilled teams we need to serve patients and families.
- Driving Health and Vitality in our Community
  We work closely with partners to redefine health beyond healthcare and with a bold vision of achieving health equity for all.
- Leading the Way in Cancer Research and Care
  We are devoted to crushing cancer here in our community and worldwide.
- Donate Now
  Your gift today makes tomorrow’s breakthroughs possible.
- Hope to Health Campaign
  An unprecedented philanthropic initiative to support our commitment to building healthy and thriving communities.
Find a Doctor

Staff Collaborate Conference Room

Pradeep Chaluvally-Raghavan, PhD

Home /
Departments /
Obstetrics & Gynecology /
Pradeep Chaluvally-Raghavan, PhD

Pradeep Chaluvally-Raghavan, PhD

Assistant Professor

Locations

Obstetrics & Gynecology

Contact Information

Biography

Department Profile

B Cells as an Immune-Regulatory Signature in Ovarian Cancer.

(Gupta P, Chen C, Chaluvally-Raghavan P, Pradeep S.) Cancers (Basel). 2019 Jun 26;11(7).
Interaction of tumor cells and astrocytes promotes breast cancer brain metastases through TGF-β2/ANGPTL4 axes.

(Gong X, Hou Z, Endsley MP, Gronseth EI, Rarick KR, Jorns JM, Yang Q, Du Z, Yan K, Bordas ML, Gershan J, Deepak P, Geethadevi A, Chaluvally-Raghavan P, Fan Y, Harder DR, Ramchandran R, Wang L.) NPJ Precis Oncol. 2019;3:24.
ERBB signaling in CTCs of ovarian cancer and glioblastoma.

(Geethadevi A, Parashar D, Bishop E, Pradeep S, Chaluvally-Raghavan P.) Genes Cancer. 2017 Nov;8(11-12):746-751.
miRNA-Mediated RNA Activation in Mammalian Cells.

(Ramchandran R, Chaluvally-Raghavan P.) Adv Exp Med Biol. 2017;983:81-89.
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.

(Chaluvally-Raghavan P, Jeong KJ, Pradeep S, Silva AM, Yu S, Liu W, Moss T, Rodriguez-Aguayo C, Zhang D, Ram P, Liu J, Lu Y, Lopez-Berestein G, Calin GA, Sood AK, Mills GB.) Cell Rep. 2016 05 17;15(7):1493-1504.
Targeting ncRNAs in the 3q26.2 amplicon.

(Chaluvally-Raghavan P, Mills GB.) Oncoscience. 2015;2(8):671-2.
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.

(Chaluvally-Raghavan P, Zhang F, Pradeep S, Hamilton MP, Zhao X, Rupaimoole R, Moss T, Lu Y, Yu S, Pecot CV, Aure MR, Peuget S, Rodriguez-Aguayo C, Han HD, Zhang D, Venkatanarayan A, Krohn M, Kristensen VN, Gagea M, Ram P, Liu W, Lopez-Berestein G, Lorenzi PL, Børresen-Dale AL, Chin K, Gray J, Dusetti NJ, McGuire SE, Flores ER, Sood AK, Mills GB.) Cancer Cell. 2014 Dec 08;26(6):863-879.
Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

(Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, Pecot CV, Kim SJ, Choi HJ, Bischoff FZ, Mayer JA, Huang L, Nick AM, Hall CS, Rodriguez-Aguayo C, Zand B, Dalton HJ, Arumugam T, Lee HJ, Han HD, Cho MS, Rupaimoole R, Mangala LS, Sehgal V, Oh SC, Liu J, Lee JS, Coleman RL, Ram P, Lopez-Berestein G, Fidler IJ, Sood AK.) Cancer Cell. 2014 Jul 14;26(1):77-91.